| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2300534 | 替雷利珠单抗注射液（皮下注射） | tislelizumab | Injection | Biological Products(2.1) | New Drug Application | 2023-08-02 | BeiGene Guangzhou Biologics Manufacturing Co Ltd | view |